Pulse Pharma Private Limited, a active private limited company, was established on 31 January 1995 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U74899DL1995PTC064858. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.95 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Jyoti Bahri (Director), Deepak Bahri (Director). Past directors included Bantwal Raghurama Prabhu, Rama Kant Sharma. It holds no open charges and ₹371.63 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 212, Ashirwad Commercial Complex D-1, Green Park, New Delhi, Delhi, 110016.
U74899DL1995PTC064858
064858
31 January 1995
₹1.00 Cr
₹7.95 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Pulse Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Bahri | Director | 31 Jan 1995 | Current |
| Deepak Bahri | Director | 31 Jan 1995 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Oct 2014 | Past |
| Pramod Abcsdd | Director | 07 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pulse Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.36% increase. The company also saw a substantial improvement in profitability, with a 187.47% increase in profit. The company's net worth moved up by a moderate rise of 0.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Pulse Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,716,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2012 | Citibank N.A | ₹7.00 Cr | Satisfied |
| 23 Aug 2008 | Canara Bank | ₹130.99 Cr | Satisfied |
| 16 May 2006 | Icici Bank Limited | ₹28.34 Cr | Satisfied |
| 03 Nov 2005 | Canara Bank | ₹102.65 Cr | Satisfied |
| 29 Sep 1999 | Canara Bank | ₹102.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Pulse Pharma has a workforce of 3 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pulse Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pulse Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pulse Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Pulse Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity A charge registered on 16 May 2006 via Charge ID 10017922 with Icici Bank Limited was fully satisfied on 25 Apr 2019. was completed.
The activity A charge registered on 23 Aug 2008 via Charge ID 10123924 with Canara Bank was fully satisfied on 14 Sep 2016. was completed.
The activity A charge registered on 03 Nov 2005 via Charge ID 80026887 with Canara Bank was fully satisfied on 14 Sep 2016. was completed.
Progress on A charge registered on 29 Sep 1999 via Charge ID 80026888 with Canara Bank was fully satisfied on 14 Sep 2016. was documented.
The CIN of Pulse Pharma Private Limited is U74899DL1995PTC064858.
Pulse Pharma Private Limited is headquartered at 212, Ashirwad Commercial Complex D-1, Green Park, New Delhi, Delhi, 110016.
Pulse Pharma Private Limited was incorporated on 31 January 1995.
The current directors of Pulse Pharma Private Limited are
The primary industry of Pulse Pharma Private Limited is Manufacturing.
Pulse Pharma Private Limited is unlisted.
The authorized capital of Pulse Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.95 M.
The compliance status of Pulse Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX